1. Home
  2. GKOS vs GTES Comparison

GKOS vs GTES Comparison

Compare GKOS & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$107.89

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Gates Industrial Corporation plc

GTES

Gates Industrial Corporation plc

HOLD

Current Price

$22.20

Market Cap

5.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
GTES
Founded
1998
1911
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.8B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
GKOS
GTES
Price
$107.89
$22.20
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$122.08
$26.45
AVG Volume (30 Days)
1.1M
2.4M
Earning Date
10-29-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.34
EPS
N/A
0.91
Revenue
$469,820,000.00
$3,416,400,000.00
Revenue This Year
$30.89
$3.05
Revenue Next Year
$24.36
$3.62
P/E Ratio
N/A
$24.49
Revenue Growth
30.38
N/A
52 Week Low
$73.16
$14.70
52 Week High
$163.71
$26.46

Technical Indicators

Market Signals
Indicator
GKOS
GTES
Relative Strength Index (RSI) 73.56 44.65
Support Level $104.11 $21.10
Resistance Level $107.18 $22.89
Average True Range (ATR) 4.40 0.56
MACD 1.26 0.17
Stochastic Oscillator 92.97 60.33

Price Performance

Historical Comparison
GKOS
GTES

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

Share on Social Networks: